Skip to main content
Clinical Trials/TCTR20230124006
TCTR20230124006
Recruiting
Phase 2

Innovative Determination of Optimal Positive Expiratory Pressure to Increase Exercise Tolerance in COPD patients

Khon Kaen University0 sites47 target enrollmentJanuary 24, 2023

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease
Sponsor
Khon Kaen University
Enrollment
47
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 24, 2023
End Date
September 7, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. COPD patients GOLD stage II to IV.
  • 2\. Age between 40 to 80 years old.
  • 3\. Good communication, cooperation, and cognition.
  • 4\. Stable COPD (without acute exacerbation in the previous 4 weeks).

Exclusion Criteria

  • 1\. Medical diagnosis history of cardiovascular disease or related to the contraindication of exercise.
  • 2\. Home oxygen therapy (for at least 15 hours per day) or SpO2 \< 88%.
  • 4\. Neuromuscular and musculoskeletal disorders.
  • 5\. Recent surgery.
  • 6\. Spontaneous bone fracture.
  • 7\. Acute lung embolism, lung infraction, or infection.
  • 8\. Severe arterial hypertension (Resting of systolic \>200 mmHg or diastolic of \>110 mmHg).

Outcomes

Primary Outcomes

Not specified

Similar Trials